טוען...
Update on the core and developing cerebrospinal fluid biomarkers for Alzheimer disease
Alzheimer disease (AD) is a complex neurodegenerative disorder, whose prevalence will dramatically rise by 2050. Despite numerous clinical trials investigating this disease, there is still no effective treatment. Many trials showed negative or inconclusive results, possibly because they recruited on...
שמור ב:
| Main Authors: | , , , , , , |
|---|---|
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Croatian Medical Schools
2014
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4157375/ https://ncbi.nlm.nih.gov/pubmed/25165049 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3325/cmj.2014.55.347 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|